Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ICMT | O60725 | 3/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 7/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.36 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.36 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.36 |
| ▸ | SELE | P16581 | 1/20 | 0.36 |
| ▸ | ASH1L | Q9NR48 | 1/20 | 0.35 |
| ▸ | FEN1 | P39748 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25429756 | 1.00 | ICMT (0.39) | ICMTTRPV1SCN9ALMNASCN5A | |
| SCHEMBL25429484 | 0.89 | SCN8A (0.43) | ICMTTRPV1SCN9ASCN5ABACE1 | |
| SCHEMBL25428113 | 0.87 | TRPV1 (0.39) | ICMTTRPV1SCN9ASCN5ASCN8A | |
| SCHEMBL30544026 | 0.87 | TRPV1 (0.39) | ICMTTRPV1SCN9ASCN5ASCN8A | |
| SCHEMBL30544057 | 0.87 | SCN9A (0.44) | ICMTTRPV1SCN9ASCN5ABACE1 | |
| SCHEMBL25952320 | 0.87 | SCN9A (0.44) | ICMTTRPV1SCN9ASCN5ABACE1 | |
| SCHEMBL25429273 | 0.84 | NOD2 (0.37) | TRPV1SCN9ASCN5ASCN8ASCN10A | |
| SCHEMBL25954187 | 0.83 | GRIN2B (0.50) | TRPV1 | |
| SCHEMBL25429629 | 0.83 | TRPV1 (0.46) | TRPV1SCN9ASCN5ABACE1 | |
| SCHEMBL30544106 | 0.81 | PDPK1 (0.40) | TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023146511-A1 | COMPOUNDS AND METHODS OF USE THEREOF | VIVACE THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |